A Phase 1b Trial in Patients With Renal Cell Cancer

Clinical trial NCT01258348 · COMPLETED

Trial details

NCT number: NCT01258348
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Renal Cell Cancer

Start date: 2008-07-01
Primary completion: 2012-02-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.